Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer
Clinical trial NCT03308201 · COMPLETED
Trial details
- NCT number
- NCT03308201
- Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2022-06-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.